The document outlines selective immunoglobulin A deficiency, defined as a serum IgA level less than 7 mg/dL in individuals over 4 years old with normal IgG, IgM, and a normal IgG antibody response to vaccination. It discusses the condition's initial description in 1964 and lists key diagnostic criteria established by immunology societies.
4. Benjasupattananan P, Simasathein T, Vichyanond P, Leungwedchakarn V, Visitsunthorn N, Pacharn P, et al. Clinical characteristics and outcomes of
primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center. Journal of clinical immunology. 2009;29:357-64.
5. Benjasupattananan P, Simasathein T, Vichyanond P, Leungwedchakarn V, Visitsunthorn N, Pacharn P, et al. Clinical characteristics and outcomes of
primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center. Journal of clinical immunology. 2009;29:357-64.
6. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
7. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
Serum Immunoglobulin Assay : IgG,IgA,IgM
8. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
9. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
B lymphocyte CD 19+
10. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
B lymphocyte CD 19+
CD 19+ absent
X-Linked
Agammaglobulinemia
11. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
B lymphocyte CD 19+
CD 19+ absent
X-Linked
Agammaglobulinemia
CD 19+ >1%
CVID
12. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
B lymphocyte CD 19+
CD 19+ absent
X-Linked
Agammaglobulinemia
CD 19+ >1%
CVID
IgG and IgA and
normal or IgM
13. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
B lymphocyte CD 19+
CD 19+ absent
X-Linked
Agammaglobulinemia
CD 19+ >1%
CVID
IgG and IgA and
normal or IgM
Transient
hypogammaglo
-bulinemia of
infancy
14. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
B lymphocyte CD 19+
CD 19+ absent
X-Linked
Agammaglobulinemia
CD 19+ >1%
CVID
IgG and IgA and
normal or IgM
Transient
hypogammaglo
-bulinemia of
infancy
15. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
B lymphocyte CD 19+
CD 19+ absent
X-Linked
Agammaglobulinemia
CD 19+ >1%
CVID
IgG and IgA and
normal or IgM
Transient
hypogammaglo
-bulinemia of
infancy
HyperIgM
syndrome
16. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
IgG and IgA and
normal or IgM
Normal
IgG,IgA,IgM
B lymphocyte CD 19+
CD 19+ absent CD 19+ >1%
X-Linked
Agammaglobulinemia
CVID
HyperIgM
syndrome
Transient
hypogammaglo
-bulinemia of
infancy
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
17. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
IgG and IgA and
normal or IgM
Normal
IgG,IgA,IgM
B lymphocyte CD 19+
CD 19+ absent CD 19+ >1%
X-Linked
Agammaglobulinemia
CVID
HyperIgM
syndrome
Transient
hypogammaglo
-bulinemia of
infancy
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
Abn Specific
Ab resonse
to vaccine
Specific
Ab def.
18. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
B lymphocyte CD 19+
CD 19+ absent
X-Linked
Agammaglobulinemia
CD 19+ >1%
CVID
IgG and IgA and
normal or IgM
Transient
hypogammaglo
-bulinemia of
infancy
HyperIgM
syndrome
IgA Normal
IgG,IgA,IgM
Abn Specific
Ab resonse
to vaccine
Specific
Ab def.
19. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
IgG and IgA and
normal or IgM
IgA Normal
IgG,IgA,IgM
B lymphocyte CD 19+
CD 19+ absent CD 19+ >1%
X-Linked
Agammaglobulinemia
CVID
HyperIgM
syndrome
Transient
hypogammaglo
-bulinemia of
infancy
Specific Ab
resonse to
vaccine
Abn Specific
Ab resonse
to vaccine
Specific
Ab def.
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
20. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
IgG and IgA and
normal or IgM
IgA Normal
IgG,IgA,IgM
B lymphocyte CD 19+
CD 19+ absent CD 19+ >1%
X-Linked
Agammaglobulinemia
CVID
HyperIgM
syndrome
Transient
hypogammaglo
-bulinemia of
infancy
Specific Ab
resonse to
vaccine
Abn Specific
Ab resonse
to vaccine
Specific
Ab def.
Low
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
21. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
IgG and IgA and
normal or IgM
IgA Normal
IgG,IgA,IgM
B lymphocyte CD 19+
CD 19+ absent CD 19+ >1%
X-Linked
Agammaglobulinemia
CVID
HyperIgM
syndrome
Transient
hypogammaglo
-bulinemia of
infancy
Specific Ab
resonse to
vaccine
IgA with
Specific
Ab def.
Abn Specific
Ab resonse
to vaccine
Specific
Ab def.
Low
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
22. Predominantly antibody deficiency
Recurrent bacterial infection
:Otitis,Pneumonia,Sinusitis,Diarrhea,Sepsis
Serum Immunoglobulin Assay : IgG,IgA,IgM
IgG,IgA and/or IgM
IgG and IgA and
normal or IgM
IgA Normal
IgG,IgA,IgM
B lymphocyte CD 19+
CD 19+ absent CD 19+ >1%
X-Linked
Agammaglobulinemia
CVID
HyperIgM
syndrome
Transient
hypogammaglo
-bulinemia of
infancy
Specific Ab
resonse to
vaccine
Selective
IgA def.
IgA with
Specific
Ab def.
Abn Specific
Ab resonse
to vaccine
Specific
Ab def.
Normal Low
Bousfiha AA, Jeddane L, Ailal F, Al Herz W, Conley ME, Cunningham-Rundles C, et al. A phenotypic approach for IUIS PID classification and
23. Selective IgA Deficiency
“First described in 1964”
Rockey JH, Hanson LA, Heremans JF, Kunkel HG. BETA-2A AGLOBULINEMIA IN TWO HEALTHY MEN. The
Journal of laboratory and clinical medicine. 1964;63:205-12.
24. Rockey JH, Hanson LA, Heremans JF, Kunkel HG. BETA-2A AGLOBULINEMIA IN TWO HEALTHY MEN. The
Journal of laboratory and clinical medicine. 1964;63:205-12.
25. Definition
•Male or female greater than 4 years of age
•Serum IgA of less than 7 mg/dL (0.07 g/L)
•Normal serum IgG and IgM
•Other causes of hypogammaglobulinemia have
been excluded
•Normal IgG antibody response to vaccination
Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for
Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clinical immunology (Orlando, Fla). 1999;93:190-7.
Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. The Journal of
allergy and clinical immunology. 2015.
26. Definition
•Male or female greater than 4 years of age
•Serum IgA of less than 7 mg/dL (0.07 g/L)
•Normal serum IgG and IgM
•Other causes of hypogammaglobulinemia have
been excluded
•Normal IgG antibody response to vaccination
Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. The Journal of
allergy and clinical immunology. 2015.
Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for
Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clinical immunology (Orlando, Fla). 1999;93:190-7.
27. Definition
•Male or female greater than 4 years of age
•Serum IgA of less than 7 mg/dL (0.07 g/L)
•Normal serum IgG and IgM
•Other causes of hypogammaglobulinemia have
been excluded
•Normal IgG antibody response to vaccination
Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. The Journal of
allergy and clinical immunology. 2015.
Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for
Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clinical immunology (Orlando, Fla). 1999;93:190-7.
28. Definition
•Male or female greater than 4 years of age
•Serum IgA of less than 7 mg/dL (0.07 g/L)
•Normal serum IgG and IgM
•Other causes of hypogammaglobulinemia have
been excluded
•Normal IgG antibody response to vaccination
Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. The Journal of
allergy and clinical immunology. 2015.
Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for
Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clinical immunology (Orlando, Fla). 1999;93:190-7.
29. Definition
•Male or female greater than 4 years of age
•Serum IgA of less than 7 mg/dL (0.07 g/L)
•Normal serum IgG and IgM
•Other causes of hypogammaglobulinemia have
been excluded
•Normal IgG antibody response to vaccination
Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for
Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clinical immunology (Orlando, Fla). 1999;93:190-7.
Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. The Journal of
allergy and clinical immunology. 2015.
30. Partial Ig A Deficiency
•Male or female greater than 4 years of age
•Serum IgA at least 2 SD below normal for age
•Normal serum IgG and IgM
Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing
PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).
Clinical immunology (Orlando, Fla). 1999;93:190-7.
32. Immunoglobulin A
“First described in serum in 1953”
Grabar P, Williams CA. [Method permitting the combined study of the electrophoretic and the
immunochemical properties of protein mixtures; application to blood serum]. Biochimica et biophysica acta.
33. Distribution
•Most abundant antibody isotypes
•60-70% of total production of antibodies
•Majority of IgA
1.Mucous secretion
:Saliva,Milk,Colostrum,Tears
2.Secretion from
:Respiratory tract ,Genitourinary tract ,Prostate
Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
Woof JM, Kerr MA. The function of immunoglobulin A in immunity. The Journal of pathology.
2006;208(2):270-82.
34. Normal Serum Level
•IgA is the second most abundant isotype in the
circulation.
•Range from 61 to 356 mg/dL.
Woof JM, Kerr MA. The function of immunoglobulin A in immunity. The Journal of pathology.
2006;208(2):270-82.
35. Jolliff CR, Cost KM, Stivrins PC, Grossman PP, Nolte CR, Franco SM, et al. Reference intervals for serum IgG,
IgA, IgM, C3, and C4 as determined by rate nephelometry. Clinical chemistry. 1982;28:126-8.
36. Figure 3-7 Basic structure of immunoglobulin molecules.
Jelinek DF,Li JT.Immunoglobulin Structure and Function In: Adkinson NF,Bochner BS, Burks AW,
Busse WW,Holgate ST, Lemanske RF, O’Hehir RE, editors. Middleton’s allergy: principles & practice. 8 th ed.
Philadelphia: Mosby-Elsevier; 2014. p.30-44.
37. Figure 3-7 Basic structure of immunoglobulin molecules.
Jelinek DF,Li JT.Immunoglobulin Structure and Function In: Adkinson NF,Bochner BS, Burks AW,
Busse WW,Holgate ST, Lemanske RF, O’Hehir RE, editors. Middleton’s allergy: principles & practice. 8 th ed.
Philadelphia: Mosby-Elsevier; 2014. p.30-44.
38. Figure 3-7 Basic structure of immunoglobulin molecules.
Jelinek DF,Li JT.Immunoglobulin Structure and Function In: Adkinson NF,Bochner BS, Burks AW,
Busse WW,Holgate ST, Lemanske RF, O’Hehir RE, editors. Middleton’s allergy: principles & practice. 8 th ed.
Philadelphia: Mosby-Elsevier; 2014. p.30-44.
39. Figure 1. Human IgA structure.
Woof JM, Russell MW. Structure and function relationships in IgA. Mucosal immunology. 2011;4:590-7.
40. Woof JM, Russell MW. Structure and function relationships in IgA. Mucosal immunology. 2011;4:590-7.
Figure 1. Human IgA structure.
41. Woof JM, Russell MW. Structure and function relationships in IgA. Mucosal immunology. 2011;4:590-7.
Figure 1. Human IgA structure.
42. Figure 3-7 Basic structure of immunoglobulin molecules.
Jelinek DF,Li JT.Immunoglobulin Structure and Function In: Adkinson NF,Bochner BS, Burks AW,
Busse WW,Holgate ST, Lemanske RF, O’Hehir RE, editors. Middleton’s allergy: principles & practice. 8 th ed.
Philadelphia: Mosby-Elsevier; 2014. p.30-44.
Monomeric Serum IgA
43. Dimeric form IgA
Woof JM, Russell MW. Structure and function relationships in IgA. Mucosal immunology. 2011;4:590-7.
Figure 1. Human IgA structure.
44. Dimeric form IgA
Woof JM, Russell MW. Structure and function relationships in IgA. Mucosal immunology. 2011;4:590-7.
Figure 1. Human IgA structure.
45. Figure 3-7 Basic structure of immunoglobulin molecules.
Jelinek DF,Li JT.Immunoglobulin Structure and Function In: Adkinson NF,Bochner BS, Burks AW,
Busse WW,Holgate ST, Lemanske RF, O’Hehir RE, editors. Middleton’s allergy: principles & practice. 8 th ed.
Philadelphia: Mosby-Elsevier; 2014. p.30-44.
Dimeric form IgA
46. Figure 3-7 Basic structure of immunoglobulin molecules.
Jelinek DF,Li JT.Immunoglobulin Structure and Function In: Adkinson NF,Bochner BS, Burks AW,
Busse WW,Holgate ST, Lemanske RF, O’Hehir RE, editors. Middleton’s allergy: principles & practice. 8 th ed.
Philadelphia: Mosby-Elsevier; 2014. p.30-44.
Dimeric form IgA
47. Production
From Plasma cell in Bone marrow
From Locally in the mucosal tissue
Woof JM, Kerr MA. The function of immunoglobulin A in immunity. The Journal of pathology. 2006;208:270-82.
Serum IgA
48. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders Company.2015.
Jelinek DF,Li JT.Immunoglobulin Structure and Function In: Adkinson NF,Bochner BS,Burks AW,Busse WW,Holgate ST,
Lemanske RF, O’Hehir RE, editors. Middleton’s allergy: principles & practice. 8 th ed. Philadelphia: Mosby-Elsevier; 2014.
p.30-44.
Figure 3-8 Germline organization of human immunoglobulin gene loci.
49. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders Company.2015.
Jelinek DF,Li JT.Immunoglobulin Structure and Function In: Adkinson NF,Bochner BS,Burks AW,Busse WW,Holgate ST,
Lemanske RF, O’Hehir RE, editors. Middleton’s allergy: principles & practice. 8 th ed. Philadelphia: Mosby-Elsevier; 2014.
p.30-44.
Figure 3-8 Germline organization of human immunoglobulin gene loci.
50. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 A IgA class switching in the gut. T-dependent IgA class switching
51. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 A IgA class switching in the gut. T-dependent IgA class switching
52. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 A IgA class switching in the gut. T-dependent IgA class switching
53. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 A IgA class switching in the gut. T-dependent IgA class switching
54. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 A IgA class switching in the gut. T-dependent IgA class switching
55. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 A IgA class switching in the gut. T-dependent IgA class switching
56. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 A IgA class switching in the gut. T-dependent IgA class switching
57. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 A IgA class switching in the gut. T-dependent IgA class switching
58. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 A IgA class switching in the gut. T-dependent IgA class switching
59. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 B IgA class switching in the gut. T-independent IgA class switching
60. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 B IgA class switching in the gut. T-independent IgA class switching
61. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 B IgA class switching in the gut. T-independent IgA class switching
62. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 B IgA class switching in the gut. T-independent IgA class switching
63. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-7 B IgA class switching in the gut. T-independent IgA class switching
64. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-8 Transport of IgA across epithelial cells.
65. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-8 Transport of IgA across epithelial cells.
66. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-8 Transport of IgA across epithelial cells.
67. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-8 Transport of IgA across epithelial cells.
68. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-8 Transport of IgA across epithelial cells.
69. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
FIGURE 14-8 Transport of IgA across epithelial cells.
70. FIGURE 3-11 Fc receptor expression pattern on human cells and biologic
activity.
Jelinek DF,Li JT.Immunoglobulin Structure and Function In: Adkinson NF,Bochner BS, Burks AW,Busse WW,Holgate ST, Lemanske RF, O’Hehir RE,
editors. Middleton’s allergy: principles & practice. 8 th ed. Philadelphia: Mosby-Elsevier; 2014. p.30-44.
71. Fig. 1 a Schematic representation of immunoglobulin A (IgA) binding to
the Fc alpha RI–FcR gammachain
Mkaddem SB, Christou I, Rossato E, Berthelot L, Lehuen A, Monteiro RC.In IgA, IgA receptors, and their anti-
inflammatory properties In : Daëron M, Nimmerjahn F,editors :Current Topics in Microbiology and
Immunology . 1st ed. Switzerland Springer International Publishing; 2014. p221-35 .
72. Fig. 2 Simplified scheme of Fc alpha RI signaling pathways
Mkaddem SB, Christou I, Rossato E, Berthelot L, Lehuen A, Monteiro RC.In IgA, IgA receptors, and their anti-
inflammatory properties In : Daëron M, Nimmerjahn F,editors :Current Topics in Microbiology and
Immunology . 1st ed. Switzerland Springer International Publishing; 2014. p221-35 .
Activation
73. Mkaddem SB, Christou I, Rossato E, Berthelot L, Lehuen A, Monteiro RC.In IgA, IgA receptors, and their anti-
inflammatory properties In : Daëron M, Nimmerjahn F,editors :Current Topics in Microbiology and
Immunology . 1st ed. Switzerland Springer International Publishing; 2014. p221-35 .
Inhibition
Fig. 1 a Schematic representation of immunoglobulin A (IgA) binding to
the Fc alpha RI–FcRc-chain
74. Fig. 1 b DC-SIGN/SIGNR1 and secretory IgA (SIgA) representation
Mkaddem SB, Christou I, Rossato E, Berthelot L, Lehuen A, Monteiro RC.In IgA, IgA receptors, and their anti-
inflammatory properties In : Daëron M, Nimmerjahn F,editors :Current Topics in Microbiology and
Immunology . 1st ed. Switzerland Springer International Publishing; 2014. p221-35 .
Regulatory
Function
79. Stem Cells Defect
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6
80. Hammarstrom L, Lonnqvist B, Ringden O, Smith CI, Wiebe T. Transfer of IgA deficiency to a bone-marrow-
grafted patient with aplastic anaemia. Lancet (London, England). 1985;1:778-81.
81. Hammarstrom L, Lonnqvist B, Ringden O, Smith CI, Wiebe T. Transfer of IgA deficiency to a bone-marrow-
grafted patient with aplastic anaemia. Lancet (London, England). 1985;1:778-81.
82. Block in differentiation of B cells to IgA antibody
secreting plasma cell
Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 8th ed.Philadelphia, W.B. Saunders
Company.2015.
83. FIG. 1. Overview of B-cell development and defects causing antibody deficiency.
Fried AJ, Bonilla FA. Pathogenesis, diagnosis, and management of primary antibody deficiencies and
infections. Clinical microbiology reviews. 2009;22:396-414.
84. Nechvatalova J, Pikulova Z, Stikarovska D, Pesak S, Vlkova M, Litzman J. B-lymphocyte subpopulations in
patients with selective IgA deficiency. Journal of clinical immunology. 2012;32(3):441-8.
85. Alpha heavy chain gene deletions
involving various segments on chromosome 14
86. Suzuki H, Kaneko H, Fukao T, Jin R, Kawamoto N, Asano T, et al. Various expression patterns of alpha1 and
alpha2 genes in IgA deficiency. Allergology international : official journal of the Japanese Society of
Allergology. 2009;58:111-7.
87. Suzuki H, Kaneko H, Fukao T, Jin R, Kawamoto N, Asano T, et al. Various expression patterns of alpha1 and
alpha2 genes in IgA deficiency. Allergology international : official journal of the Japanese Society of
Allergology. 2009;58:111-7.
89. Rachid R, Castigli E, Geha RS, Bonilla FA. TACI mutation in common variable immunodeficiency and IgA
deficiency. Current allergy and asthma reports. 2006;6:357-62.
90. Abnormality of The Cytokine network
Cunningham-Rundles C. Physiology of IgA and IgA deficiency. JClin Immunol. 2001;21:303–9.
91. • IL-4
• IL-6
• IL-7
• IL-10
• TGF-β
• IL-21
Cunningham-Rundles C. Physiology of IgA and IgA deficiency. JClin Immunol. 2001;21:303–9.
94. The 8.1 Haplotype
MHC Haplotype
A1,B8,DR3,DQ2
Wikipedia. HLA A1-B8-DR3-DQ2 [Internet]. 2015 [cited 2015 Sep 19]. Available from:
http://en.wikipedia.org/wiki/HLA A1-B8-DR3-DQ2
95. The 8.1 Haplotype
MHC Haplotype
A1,B8,DR3,DQ2
IgA deficiency Patients Healthy polpulation
45% 16%
Singh K, Chang C, Gershwin ME. IgA deficiency and autoimmunity. Autoimmunity reviews. 2014;13:163-77.
96. Mohammadi J, Ramanujam R, Jarefors S, Rezaei N, Aghamohammadi A, Gregersen PK, et al. IgA deficiency
and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1)
haplotype. Journal of clinical immunology. 2010;30:138-43.
98. IF1H1 =Interferon induced with helicase C domain 1 protein
Ferreira RC, Pan-Hammarstrom Q, Graham RR, Gateva V, Fontan G, Lee AT, et al. Association of IFIH1 and
other autoimmunity risk alleles with selective IgA deficiency. Nature genetics. 2010;42(9):777-80.
99. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al. Selective IgA deficiency in autoimmune
diseases. Molecular medicine (Cambridge, Mass). 2011;17(11-12):1383-96.
100. CLEC 16 A =C-type lectin domain family 16
Ferreira RC, Pan-Hammarstrom Q, Graham RR, Gateva V, Fontan G, Lee AT, et al. Association of IFIH1 and
other autoimmunity risk alleles with selective IgA deficiency. Nature genetics. 2010;42(9):777-80.
101. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al. Selective IgA deficiency in autoimmune
diseases. Molecular medicine (Cambridge, Mass). 2011;17(11-12):1383-96.
102. 18q deletion syndrome
Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and
management of primary immunodeficiency. The Journal of allergy and clinical immunology. 2015.
103. IgG4 deficiency
Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and
management of primary immunodeficiency. The Journal of allergy and clinical immunology. 2015.
105. IgA deficiency is more common in
Caucasians.
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6
106. Country Prevalence
Arabian peninsula 1:143
Spain 1:163
Nigeria 1:252
England 1:875
Brazil 1:965
USA 1:223 to 1:1,000
China 1:2,600 to 1:5,300
Japan 1:14,840 to 1:18,500
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6
107. Phankingthongkum S, Visitsunthorn N, Vichyanond P. IgA deficiency: a report of three cases from Thailand. Asian Pacific
journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand. 2002;20:203-7.
109. Wide spectrum of clinical findings
• Asymtomatic
• Recurrent sinopulmonary infections
• Gastrointestinal infections and disorders
• Allergic disorder
• Autoimmune conditions
• Malignancies
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6
110. Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to
pneumococcal vaccine. Clinical immunology (Orlando, Fla). 2004;111:93-7.
111. Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to
pneumococcal vaccine. Clinical immunology (Orlando, Fla). 2004;111:93-7.
112. Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to
pneumococcal vaccine. Clinical immunology (Orlando, Fla). 2004;111:93-7.
113. Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to
pneumococcal vaccine. Clinical immunology (Orlando, Fla). 2004;111:93-7.
114. Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to
pneumococcal vaccine. Clinical immunology (Orlando, Fla). 2004;111:93-7.
115. Recurrent sinopulmonary infections
Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to
pneumococcal vaccine. Clinical immunology (Orlando, Fla). 2004;111:93-7.
116. Aghamohammadi A, Cheraghi T, Gharagozlou M, Movahedi M, Rezaei N, Yeganeh M, et al. IgA deficiency:
correlation between clinical and immunological phenotypes. Journal of clinical immunology. 2009;29:130-6.
117. Chipps BE, Talamo RC, Winkelstein JA. IgA deficiency, recurrent pneumonias, and bronchiectasis. Chest.
1978;73:519-26.
118. Chipps BE, Talamo RC, Winkelstein JA. IgA deficiency, recurrent pneumonias, and bronchiectasis. Chest.
119. Gastrointestinal infections and disorders
•Giardia lamblia
•Malabsorption
•Celiac disease
•Ulcerative colitis
•Nodular lymphoid hyperpalsia
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6
120. Gastrointestinal infections and disorders
•Giardia lamblia
•Malabsorption
•Celiac disease
•Ulcerative colitis
•Nodular lymphoid hyperpalsia
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6
121. Eren M, Saltik-Temizel IN, Yuce A, Caglar M, Kocak N. Duodenal appearance of giardiasis in a child with
selective immunoglobulin A deficiency. Pediatrics international : official journal of the Japan Pediatric
122. Eren M, Saltik-Temizel IN, Yuce A, Caglar M, Kocak N. Duodenal appearance of giardiasis in a child with selective immunoglobulin A deficiency
Pediatrics international : official journal of the Japan Pediatric Society. 2007;49(3):409-11
123. Gastrointestinal infections and disorders
•Giardia lamblia
•Malabsorption
•Celiac disease
•Ulcerative colitis
•Nodular lymphoid hyperpalsia
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6
124. Gastrointestinal infections and disorders
•Giardia lamblia
•Malabsorption
•Celiac disease
•Ulcerative colitis
•Nodular lymphoid hyperpalsia
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6
125. Figure 1 Endoscopic appearance of nodular lymphoid hyperplasia.
• In immunodeficiency
states
• To compensate functional
inadequate intestinal
lymphoid tissue.
• NLH result from an
accumulation of plasma-
cell precursors.
Albuquerque A. Nodular lymphoid hyperplasia in the gastrointestinal tract in adult patients: A review. World
journal of gastrointestinal endoscopy. 2014;6:534-40.
126. Allergic disorder
Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to
pneumococcal vaccine. Clinical immunology (Orlando, Fla). 2004;111:93-7.
127. Aghamohammadi A, Cheraghi T, Gharagozlou M, Movahedi M, Rezaei N, Yeganeh M, et al. IgA deficiency:
correlation between clinical and immunological phenotypes. Journal of clinical immunology. 2009;29:130-6.
128. Autoimmune conditions
•This figure varies from 3.3 % to 33.6 %based
on the age range of studied populations .
Singh K, Chang C, Gershwin ME. IgA deficiency and autoimmunity. Autoimmunity reviews. 2014;13:163-77.
129. Why IgA deficiency may be associated with
autoimmunity?
•Genetic factor
: HLA haplotypes 8.1
•Ig A protect against immunity
:IgA interaction with FCR alpha RI
•Anti-bovine immunoprecipitins in IgA def. pt.
Singh K, Chang C, Gershwin ME. IgA deficiency and autoimmunity. Autoimmunity reviews. 2014;13:163-77.
130. Why IgA deficiency may be associated with
autoimmunity?
•Genetic factor
: HLA haplotypes 8.1
•Ig A protect against immunity
:IgA interaction with FCR alpha RI
•Anti-bovine immunoprecipitins in IgA def. pt.
Singh K, Chang C, Gershwin ME. IgA deficiency and autoimmunity. Autoimmunity reviews. 2014;13:163-77.
131. Why IgA deficiency may be associated with
autoimmunity?
•Genetic factor
: HLA haplotypes 8.1
•Ig A protect against immunity
:IgA interaction with FCR alpha RI
•Anti-bovine immunoprecipitins in IgA def. pt.
Singh K, Chang C, Gershwin ME. IgA deficiency and autoimmunity. Autoimmunity reviews. 2014;13:163-77.
132. Mkaddem SB, Christou I, Rossato E, Berthelot L, Lehuen A, Monteiro RC.In IgA, IgA receptors, and their anti-
inflammatory properties In : Daëron M, Nimmerjahn F,editors :Current Topics in Microbiology and
Immunology . 1st ed. Switzerland Springer International Publishing; 2014. p221-35 .
Inhibition
Fig. 1 a Schematic representation of immunoglobulin A (IgA) binding to
the Fc alpha RI–FcRc-chain
133. Why IgA deficiency may be associated with
autoimmunity?
•Genetic factor
: HLA haplotypes 8.1
•Ig A protect against immunity
:IgA interaction with FCR alpha RI
•Anti-bovine immunoprecipitins in IgA def. pt.
Singh K, Chang C, Gershwin ME. IgA deficiency and autoimmunity. Autoimmunity reviews. 2014;13:163-77.
134. Autoimmune conditions
Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to
pneumococcal vaccine. Clinical immunology (Orlando, Fla). 2004;111:93-7.
135. Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to
pneumococcal vaccine. Clinical immunology (Orlando, Fla). 2004;111:93-7.
136. Aghamohammadi A, Cheraghi T, Gharagozlou M, Movahedi M, Rezaei N, Yeganeh M, et al. IgA deficiency:
correlation between clinical and immunological phenotypes. Journal of clinical immunology. 2009;29:130-6.
137. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al. Selective IgA deficiency in autoimmune
diseases. Molecular medicine (Cambridge, Mass). 2011;17:1383-96.
138. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al. Selective IgA deficiency in autoimmune
diseases. Molecular medicine (Cambridge, Mass). 2011;17:1383-96.
139. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al. Selective IgA deficiency in autoimmune
diseases. Molecular medicine (Cambridge, Mass). 2011;17:1383-96.
140. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al. Selective IgA deficiency in autoimmune
diseases. Molecular medicine (Cambridge, Mass). 2011;17:1383-96.
141. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al. Selective IgA deficiency in autoimmune
diseases. Molecular medicine (Cambridge, Mass). 2011;17:1383-96.
142. Wang N, Shen N, Vyse TJ, Anand V, Gunnarson I, Sturfelt G, et al. Selective IgA deficiency in autoimmune
diseases. Molecular medicine (Cambridge, Mass). 2011;17:1383-96.
143. Celiac Disease
Fasano A, Catassi C. Clinical practice. Celiac disease. The New England journal of medicine. 2012;367:2419-26.
144. Celiac Disease
Fasano A, Catassi C. Clinical practice. Celiac disease. The New England journal of medicine. 2012;367:2419-26.
145. Anti IgA antibody
Feng ML, Zhao YL, Shen T, Huang H, Yin B, Liu RZ, et al. Prevalence of immunoglobulin A deficiency in Chinese
blood donors and evaluation of anaphylactic transfusion reaction risk. Transfusion medicine (Oxford,
England). 2011;21:338-43.
146. Malignancies
Edwards E, Razvi S, Cunningham-Rundles C. IgA deficiency: clinical correlates and responses to
pneumococcal vaccine. Clinical immunology (Orlando, Fla). 2004;111:93-7.
147. Table 2 Malignancies and person-years
Ludvigsson JF, Neovius M, Ye W, Hammarstrom L. IgA deficiency and risk of cancer: a population-based
matched cohort study. Journal of clinical immunology. 2015;35:182-8.
148. Table 2 Malignancies and person-years
Ludvigsson JF, Neovius M, Ye W, Hammarstrom L. IgA deficiency and risk of cancer: a population-based
matched cohort study. Journal of clinical immunology. 2015;35:182-8.
149. Table 2 Malignancies and person-years
Ludvigsson JF, Neovius M, Ye W, Hammarstrom L. IgA deficiency and risk of cancer: a population-based
matched cohort study. Journal of clinical immunology. 2015;35:182-8.
150. Fig. 1 Malignancies in IgAD
(IgA deficiency) patients and
matched general population
comparators over 25 years of
follow-up
• During follow-up
• 125 pts with IgA def.
(61/10,000 person-years)
• 984 controls (47/10,000
person-years)
• Developed cancer
• HR 1.31; 95%CI = 1.09-1.58
Ludvigsson JF, Neovius M, Ye W, Hammarstrom L. IgA deficiency and risk of cancer: a population-based
matched cohort study. Journal of clinical immunology. 2015;35:182-8.
151. Table 2 Malignancies and person-years :Conditional hazard ratio
Ludvigsson JF, Neovius M, Ye W, Hammarstrom L. IgA deficiency and risk of cancer: a population-based
matched cohort study. Journal of clinical immunology. 2015;35:182-8.
153. IgA deficiency should be a consideration in a
patient with…?
•Recurrent respiratory infections
•Recurrent gastrointestinal infections
•Allergic disorders
•Autoimmune disorders
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6.
154. Immunologic evaluation for IgA deficiency is
also warranted in…?
•Case of anaphylaxis secondary to a blood
product transfusion
•Celiac disease
•Family history of IgA deficiency and/or CVID.
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6.
155. Hammarstrom L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable
immunodeficiency (CVID). Clinical and experimental immunology. 2000;120:225-31.
156. Evaluation of a suspected IgA deficiency
•Complete blood count
•Quantitative serum immunoglobulin levels
•Serum IgG subclasses
•Specific antibody response to protein &
polysaccharide antigens
•Lymphocyte subsets
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6.
157. Definition
•Male or female greater than 4 years of age
•Serum IgA of less than 7 mg/dL (0.07 g/L)
•Normal serum IgG and IgM
•Other causes of hypogammaglobulinemia have
been excluded
•Normal IgG antibody response to vaccination
Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for
Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clinical immunology (Orlando, Fla). 1999;93:190-7.
Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. The Journal of
allergy and clinical immunology. 2015.
159. Asymptomatic IgA deficiency
1. Do not need any treatment
2. Awareness & Education to prevent anaphylactic
reaction from blood transfusion
2.1 Wear a medical alert bracelet
2.2 Receive washed normal donor erythrocytes or
blood product from IgA def. person
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6.
Buckley RH,Orange JS. Primary Immunodeficiency Diseases In: Adkinson NF,Bochner BS, Burks AW, Busse WW,Holgate ST,
Lemanske RF, O’Hehir RE, editors. Middleton’s allergy: principles & practice. 8 th ed. Philadelphia: Mosby-Elsevier; 2014.
p.1144-74.
160. Asymptomatic IgA deficiency
1. Do not need any treatment
2. Awareness & Education to prevent anaphylactic
reaction from blood transfusion
2.1 Wear a medical alert bracelet
2.2 Receive washed normal donor erythrocytes or
blood product from IgA def. person
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6.
Buckley RH,Orange JS. Primary Immunodeficiency Diseases In: Adkinson NF,Bochner BS, Burks AW, Busse WW,Holgate ST,
Lemanske RF, O’Hehir RE, editors. Middleton’s allergy: principles & practice. 8 th ed. Philadelphia: Mosby-Elsevier; 2014.
p.1144-74.
161. • The patient has sIgAD
• The patient is at risk for an allergic reaction to
any injected plasma-containing blood products
& testing for anti-IgA antibodies should be
performed before such blood products are
administered.
Medical Alert Bracelet
162. • 19-year-old woman
• End-stage Type 2 autoimmune hepatitis required liver transplantation
• She also had sIgAD, anti-IgA antibodies
• Episodes of anaphylaxis after receiving IgA-containing blood products
• Plan tx with Liver transplantation
Kiani-Alikhan S, Yong PF, Grosse-Kreul D, Height SE, Mijovic A, Suddle AR, et al. Successful desensitization to
immunoglobulin A in a case of transfusion-related anaphylaxis. Transfusion. 2010;50:1897-901.
163. Time
(hr)
Pentaglobin
6 mg/mL IgA
Concentration
Rate
0.5 10-7 0.4 ml/kg/hr
1.0 10-6 0.4 ml/kg/hr
1.5 10-5 0.4 ml/kg/hr
2.0 10-4 0.4 ml/kg/hr
2.5 10-3 0.4 ml/kg/hr
3.0 10-2 0.4ml/kg/hr
3.5 10-1 0.4ml/kg/hr
4.0 10-0 32 ml /hr (100 ml)
Immunoglobulin A desensitization Protocol day 1
164. • Day 2 :Standard Plts IV infusion of 3 mL ->30 mL->300 mL
• Day 3 :Standard FFP 3 units
• Day 4 & 5 :Standard RBCs3 units with no adverse reactions
• Day… :Weekly IV infusions of IgA-enriched immunoglobulins continue
until after a successful liver transplantation
Kiani-Alikhan S, Yong PF, Grosse-Kreul D, Height SE, Mijovic A, Suddle AR, et al. Successful desensitization to
immunoglobulin A in a case of transfusion-related anaphylaxis. Transfusion. 2010;50:1897-901.
165. Indication for Screening anti IgA Autoantibody
1. Severe sIgAD
2. Partial sIgAD (and other pts) who have
experienced an infusion reaction to a blood
product
166. IgA deficiency with Associate disease
1. Recurrent infections :Prophylactic antibiotics
2. Allergic disorder : Standard treatment
3. Autoimmune condition : Standard treatment
Yel L. Selective IgA deficiency. Journal of clinical immunology. 2010;30:10-6.
Buckley RH,Orange JS. Primary Immunodeficiency Diseases In: Adkinson NF,Bochner BS, Burks AW, Busse WW,Holgate ST,
Lemanske RF, O’Hehir RE, editors. Middleton’s allergy: principles & practice. 8 th ed. Philadelphia: Mosby-Elsevier; 2014.
p.1144-74.
167. Vaccination and IgA deficiency
Contraindicated
Vaccines
Risk-Specific
Recommended
Vaccines
Effectiveness &
Comments
-OPV
-BCG
-Yellow fever
-Other live vaccines
appear to be safe.
Pneumococcal All vaccines likely
effective. Immune
response might be
attenuated.
http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appenciec/A/immuno-table.pdf
168. Immunoglobulin Replacement Therapy
•Recurrent infections &Poor quality of life
•Fail aggressive ATB therapy & prophylaxis
•Intolerable side effects or hypersensitivity to ATB
Bonilla FA, Khan DA, Ballas ZK, Chinen J, Frank MM, Hsu JT, et al. Practice parameter for the diagnosis and
management of primary immunodeficiency. The Journal of allergy and clinical immunology. 2015.
169. Novel Therapy
•Stimulation CD40/anti CD40 together
with IL-4 & IL 10
•IL-21
Wang N, Hammarstrom L. IgA deficiency: what is new? Current opinion in allergy and clinical immunology.
2012;12(6):602-8.
171. Clinical heterogeneity and reversibility of selective
immunoglobulin A deficiency in 80 children.
Plebani A, Ugazio AG, Monafo V, Burgio GR. Clinical heterogeneity and reversibility of selective
immunoglobulin A deficiency in 80 children. Lancet (London, England). 1986:829-31.
40 children with
severe sIgAD
40 children with
partial sIgAD
Serum IgA level
remain low
20 children
Serum IgA level
return normal
4 Years F/U
172. Aghamohammadi A, Mohammadi J, Parvaneh N, Rezaei N, Moin M, Espanol T, et al. Progression of selective IgA deficiency
Time of Progression from Selective IgA Def to CVID from 7 months to 27 years
173. Take Home Message
•IgA deficiency is the most common PID.
•Decreased serum IgA level in the presence of
normal level of other Ig isotype.
•Most individuals with IgA deficiency are
asymptomatic.
174. Take Home Message
•Some patient may present with
: Recurrent infections of the respiratory &
gastrointestinal tracts
: Allergic disorders
: Autoimmune manifestations